Aquarius Surgical Technologies Inc.
AQQRF
$0.0042
$0.000.00%
| Weiss Ratings | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.20 | |||
| Price History | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | -79.00% | |||
| 3-Year Total Return | -28.81% | |||
| 5-Year Total Return | -98.44% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Dec 14, 2023 | |||
| 52-Week High Price (Date) | Dec 14, 2023 | |||
| Valuation | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 390.42K | |||
| Enterprise Value | 3.39M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | 12.44% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.05 | |||
| Price/Book (Q) | -0.03 | |||
| Enterprise Value/Revenue (TTM) | 26.10 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -7.97 | |||
| Enterprise Value/EBIT | -7.70 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 27.60M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 877 740 2784 | |||
| Address | 89 Scollard Street Toronto, ON M5R 1G4 | |||
| Website | aquariussurgical.com | |||
| Country | Canada | |||
| Year Founded | 1986 | |||
| Profitability | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -338.79% | |||
| Profit Margin | -553.38% | |||
| Management Effectiveness | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -58.30% | |||
| Return on Equity | -- | |||
| Income Statement | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 112.40K | |||
| Total Revenue (TTM) | 112.40K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 59.10K | |||
| EBITDA (TTM) | -368.10K | |||
| EBIT (TTM) | -380.80K | |||
| Net Income (TTM) | -622.00K | |||
| Net Income Avl. to Common (TTM) | -622.00K | |||
| Total Revenue Growth (Q YOY) | -40.22% | |||
| Earnings Growth (Q YOY) | -29.38% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | -31.11% | |||
| Balance Sheet | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.50K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 68.70K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -3.74M | |||
| Current Ratio (Q) | 0.047 | |||
| Book Value Per Share (Q) | -$0.14 | |||
| Total Assets (Q) | 339.80K | |||
| Total Current Liabilities (Q) | 1.45M | |||
| Total Debt (Q) | 3.15M | |||
| Total Liabilities (Q) | 4.08M | |||
| Total Common Equity (Q) | -3.74M | |||
| Cash Flow | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 0.00 | |||
| Cash from Financing (TTM) | 126.30K | |||
| Net Change in Cash (TTM) | -78.60K | |||
| Levered Free Cash Flow (TTM) | -192.90K | |||
| Cash from Operations (TTM) | -204.90K | |||
